Results 11 to 20 of about 76,424 (294)

Relationship between clozapine exposure and the onset of appendicitis in schizophrenia patients: a retrospective cohort study

open access: yesBMC Psychiatry, 2022
Objective Clozapine may cause serious side effects despite benefits in patients with schizophrenia. Thus, an accurate understanding of the side-effect profile of clozapine is extremely important in the management of its administration to patients with ...
Yuta Kawakita   +6 more
doaj   +1 more source

Clozapine prescribing during follow-up of a first-episode psychosis cohort

open access: yesEuropean Psychiatry, 2021
Introduction Of those with schizophrenia, one third develop treatment-resistant illness. Nearly 60% of these benefit from clozapine- the only antipsychotic medication licensed in this group.
R. Rowntree   +7 more
doaj   +1 more source

Successful clozapine rechallenge after neutropenia using lithium carbonate : a case report

open access: yesEuropean Psychiatry, 2022
Introduction Clozapine is widely known as the drug of choice in treating refractory schizophrenia. However, clozapine prescription requires close clinical and biological monitoring to prevent harmful side effects like agranulocytosis, neutropenia and ...
D. Khattech   +5 more
doaj   +1 more source

Sex differences in plasma clozapine and norclozapine concentrations in clinical practice and in relation to body mass index and plasma glucose concentrations: a retrospective survey [PDF]

open access: yes, 2015
Background Clozapine is widely prescribed and, although effective, can cause weight gain and dysglycemia. The dysmetabolic effects of clozapine are thought to be more prevalent in women with this gender on average attaining 17 % higher plasma clozapine ...
Anderson, Simon G.   +7 more
core   +2 more sources

Clozapine generates obsessive compulsive disorder-like behavior in mice

open access: yesMolecular Brain, 2020
Clozapine is thought to induce obsessive compulsive symptoms (OCS) in schizophrenic patients. However, because OCS are often comorbid with schizophrenia regardless of clozapine treatment, it remains unclear whether clozapine can generate OCS de novo ...
Shinwon Kang   +9 more
doaj   +1 more source

Clozapine use at a specialised psychiatric hospital in Johannesburg

open access: yesSouth African Journal of Psychiatry, 2023
Background: Clozapine is the gold standard medication for treatment-resistant psychosis, with robust evidence supporting its efficacy in multiple symptom domains.
Katherine L. Ord, Belinda Marais
doaj   +1 more source

Clozapine intoxication with severe adverse effects induced by an inflammatory and infectious process: a case report

open access: yesJournal of Medical Case Reports, 2021
Background Clozapine intoxication can be life-threatening. Outside of the common drug–drug interactions, tobacco smoking, and caffeine consumption, infectious and inflammatory processes are important contributors to clozapine intoxication.
Emmanuel Bebawi   +2 more
doaj   +1 more source

A molecular basis for selective antagonist destabilization of dopamine D3 receptor quaternary organization [PDF]

open access: yes, 2017
The dopamine D3 receptor (D3R) is a molecular target for both first-generation and several recently-developed antipsychotic agents. Following stable expression of this mEGFP-tagged receptor, Spatial Intensity Distribution Analysis indicated that a ...
Caltabiano, Gianluigi   +6 more
core   +2 more sources

Tubulin/microtubules as novel clozapine targets

open access: yesNeuropsychopharmacology Reports, 2022
Aim Clozapine is currently the only effective drug for treatment‐resistant schizophrenia; nonetheless, its pharmacological mechanism remains unclear, and its administration is limited because of severe adverse effects.
Mizuki Hino   +7 more
doaj   +1 more source

Clozapine as add-on medication in the maintenance treatment of bipolar and schizoaffective disorders - A case series [PDF]

open access: yes, 2002
Atypical neuroleptics are increasingly used in the treatment of bipolar and schizoaffective disorders. Currently, numerous controlled short-term studies are available for clozapine, olanzapine, risperidone or quetiapine, but long-term data are still ...
Amann, B.   +5 more
core   +1 more source

Home - About - Disclaimer - Privacy